Demystifying the Science behind Targeted Treatments and Immunotherapies for Malignant Melanoma Virtual Study Day
Over the course of one morning Dr Elaine Vickers provides an up-to-date overview of the science behind targeted treatments and immunotherapies for people with malignant melanoma.
Event: Study day
Elaine begins with the gene mutations that cause melanoma and describes the biology of this disease and its relationship with the immune system. She then describes various treatment approaches, such as B-Raf and MEK inhibitors and immunotherapy with checkpoint inhibitors.
DAY 1-TT and Immunotherapies for Malignant Melanoma_0.pdf
Science Communicated events calendar 2021-2023_1.pdf